Solid cancers generally contain areas with lower levels of oxygen in comparison to normal tissues, meaning that cancer cells adapt to such hypoxic conditions. Targeted cancer therapy could be achieved by developing targeting molecules that are specific to regulatory mechanisms activated by tumour hypoxia.
Further information: cordis.europa.eu